Dr Scherjon comments:
The most obvious difference in the analysis presented in the letter of Kempley et al and our study is that our analysis is based on 10 longitudinal measurements, instead of two point measurements. We are therefore able to analyse the contribution of several variables to a repeated measurement model.
We used values of MAP and Pco2 (as did Kempley), but also analysed both variables as covariates changing over time. Thus the effect of MAP and PCo2 both on the patient specific level of CBFV and the within patient time course on CBFV could be estimated. Secondly, our model included gestational age as a possible confounding variable. The latter seems to be essential in the interpretation of the results. Growth retardation (IUGR) was defined by a raised antenatal umbilical/ cerebral pulsatility index ratio (U'/C'): an index indicating fetal haemodynamic redistribution and very strictly related to neonatal birthweight. I For this reply a more classic definition of SGA, using the fetal growth ratio (FGR), was used. The lower limit for appropriate fetal growth was 80%, corresponding to the 4-3 birthweight centile.2
If gestational age is not included in the model (table 1) MAP has a significant contribution to CBFV; if gestational age is included in the model its contribution disappears.
Interestingly, the interaction component between IUGR grouping and MAPtrend appeared to be significant only for the FGR definition. This suggests that there might be a different effect of MAPtrend on CBFV for IUGR compared with non-IUGR infants (IUGR defined by FGR and not by the U'/C' ratio).
We therefore repeated the analysis for the babies at risk of NAS. Of these, two (5%) had mothers with a history of drug use who denied current use, one (3%) mother took codeine, five (13%) used heroin, 22 (56%) used methadone and nine (23%) did not use opiates at all (largely alcohol and amphetamines). Of the mothers using methadone, five (23%) took methadone alone, eight (36%) took heroin in early pregnancy followed by methadone as part of a detoxification regimen, and nine (41%) were polypharmacy users. The median time to onset of withdrawal for the methadone group was 30 hours (range 0-7 days) and for the heroin group 1-5 (range 1-2) days. Median duration of medical treatment for the methadone group was 23 (range 0-80) days and for the heroin group, 4-5 (range 0-8) days. The median length of stay in hospital for the methadone group was 22-5 (range 6-107) days -one baby was successfully withdrawn from morphine at home under close supervision -the median for the heroin group was 12-5 (range 7-15) days.
Of the babies exposed to methadone, 18 (81%) were placed at home, the others being fostered. Follow up appointments at this hospital were kept by 12 (55%) babies, two (9%) attended for appointments at referring hospitals, two (9%) moved and were offered follow up with a local paediatrician (outcome unknown), and six (27%) were chronic nonattenders. Of the heroin group, one baby was adopted and the rest stayed with their mothers. Two (40%) were followed up on more than one occasion, one attended outpatients only once, and two (40%) never attended. There was one death in a baby exposed to methadone and heroin who died at the age of 6 weeks from meningococcal septicaemia.
Even though the Liverpool figures suggest an earlier and less severe withdrawal from methadone than has previously been suggested2 we cannot be certain that the mothers were not taking heroin in addition to methadone. Our figures suggest a wider range of onset and a more protracted course of NAS with methadone. We would caution paediatricians to be aware of the pattern of local drug use before altering observation policy for NAS on the basis of one paper. This report of a cardiac arrest in a neonate, after a rapid intravenous infection of vancomycin, strengthens the usual recommendation that this drug should be administered over a prolonged time. The proportion of young children (four out of five) among the reported cases might suggest that a rapid infusion of vancomycin could particularly lead to a cardiac arrest in this age group. This major side effect of vancomycin could be related to a neuromuscular blockage or a ventricular arrhythmia,2 a direct transient depression of the cardiac function,3 or an extreme form of an anaphylactoid reaction. Intestinal dilatation in the fetus EDITOR,-Richards and Holmes have described a series of nine cases with intestinal dilatation in the fetus, all with surgical We admitted a baby girl after delivery, for observation and investigations for similar findings on antenatal ultrasound scan (figure). Physical examination was unremarkable as was a plain x-ray picture of the abdomen. Stools had the consistency of urine and could only be collected with a Foley's catheter in the rectum. Diagnosis of chloride diarrhoea was confirmed by a stool chloride of 137 mmolI/1.3 She responded satisfactorily to adequate fluid and electrolyte replacement.
It is quite easy to confuse the watery stools of congenital chloride diarrhoea with urine and thus miss the diagnosis. In an apparently normal child with a history of intestinal dilatation in the antenatal period, examination of the stools should be done before any invasive procedure such as suction biopsy. Guidance after twin and singleton death EDITOR,-In relation to the perinatal death of a twin baby Dr de Kleine and colleagues recommend that all parents should be given a photograph of their babies together, as well as separately.' Not all patents would feel comfortable about displaying a photograph of a stillborn baby, but an attractive picture of the two babies can readily be created (sometimes from two separate photographs). We would be happy to provide names of artists prepared to do this.
